CML Accelerated Phase
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of HS-10382 in Patients With Chronic Myeloid Leukemia. (NCT05367700) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2022-04-28 |
Track CML Accelerated Phase automatically
Every clearance here is in the API, with alerts when new ones post.